Cargando…

Natural history of motor symptoms in Parkinson’s disease and the long-duration response to levodopa

The natural pattern of progression of Parkinson’s disease is largely unknown because patients are conventionally followed on treatment. As Parkinson’s disease progresses, the true magnitude of the long-duration response to levodopa remains unknown, because it can only be estimated indirectly in trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cilia, Roberto, Cereda, Emanuele, Akpalu, Albert, Sarfo, Fred Stephen, Cham, Momodou, Laryea, Ruth, Obese, Vida, Oppon, Kenneth, Del Sorbo, Francesca, Bonvegna, Salvatore, Zecchinelli, Anna Lena, Pezzoli, Gianni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566883/ https://www.ncbi.nlm.nih.gov/pubmed/32844196 http://dx.doi.org/10.1093/brain/awaa181

Ejemplares similares

The modern pre-levodopa era of Parkinson’s disease: insights into motor complications from sub-Saharan Africa
por: Cilia, Roberto, et al.
Publicado: (2014)

Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
por: Cereda, Emanuele, et al.
Publicado: (2017)

Erratum to: Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
por: Cereda, Emanuele, et al.
Publicado: (2017)

Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy
por: Cereda, Emanuele, et al.
Publicado: (2021)

Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
por: Garrì, Federica, et al.
Publicado: (2022)

Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
por: Garrì, Federica, et al.
Publicado: (2022)

Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study
por: Cilia, Roberto, et al.
Publicado: (2023)

The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD
por: Straniero, Letizia, et al.
Publicado: (2020)

Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment (SMAART): study protocol for a randomized controlled trial
por: Sarfo, Fred Stephen, et al.
Publicado: (2018)

Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
por: Morgante, Francesca, et al.
Publicado: (2020)

Onset and mortality of Parkinson’s disease in relation to type II diabetes
por: Pezzoli, Gianni, et al.
Publicado: (2022)

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study
por: Cilia, Roberto, et al.
Publicado: (2017)

Role of Lysosomal Gene Variants in Modulating GBA ‐Associated Parkinson's Disease Risk
por: Straniero, Letizia, et al.
Publicado: (2022)

Divergent Thinking in Parkinsonism: A Case–Control Study
por: Canesi, Margherita, et al.
Publicado: (2017)

Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications
por: Adamiak-Giera, Urszula, et al.
Publicado: (2021)

Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging study
por: Brumberg, Joachim, et al.
Publicado: (2017)

Development and Validation of a New LC-MS/MS Bioanalytical Method for the Simultaneous Determination of Levodopa, Levodopa Methyl Ester, and Carbidopa in Human Plasma Samples
por: Molteni, Linda, et al.
Publicado: (2023)

Cerebellum in Levodopa-Induced Dyskinesias: The Unusual Suspect in the Motor Network
por: Kishore, Asha, et al.
Publicado: (2014)

Asymmetrical Effect of Levodopa on the Neural Activity of Motor Regions in PD
por: Martinu, Kristina, et al.
Publicado: (2014)

Gene polymorphisms and motor levodopa‐induced complications in Parkinson's disease
por: Michałowska, Małgorzata, et al.
Publicado: (2020)

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease
por: Hauser, Robert A, et al.
Publicado: (2018)

Diabetes and Risk of Parkinson’s Disease: A systematic review and meta-analysis
por: Cereda, Emanuele, et al.
Publicado: (2011)

Explaining the lower usage rate of indigenous construction materials in Ghanaian public buildings using bounded rationality
por: Mensah, Sarfo, et al.
Publicado: (2023)

Neurological disorders encountered at an out-patient clinic in Ghana's largest medical center: A 16-year review
por: Akpalu, Albert, et al.
Publicado: (2021)

α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson’s disease
por: Mazzetti, Samanta, et al.
Publicado: (2020)

Cerebellar stimulation prevents Levodopa-induced dyskinesia in mice and normalizes activity in a motor network
por: Coutant, Bérénice, et al.
Publicado: (2022)

Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study
por: Sarfo-Kantanka, Osei, et al.
Publicado: (2017)

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
por: Borgohain, Rupam, et al.
Publicado: (2014)

Efficacy and motor complications of original and generic levodopa in Parkinson’s disease treatment
por: Kasemsap, Narongrit, et al.
Publicado: (2016)

Structural MRI substrate of long-duration response to levodopa in Parkinson’s disease: an exploratory study
por: Donzuso, Giulia, et al.
Publicado: (2021)

Profile of neurological disorders in an adult neurology clinic in Kumasi, Ghana
por: Sarfo, Fred Stephen, et al.
Publicado: (2016)

Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
por: Virmani, Tuhin, et al.
Publicado: (2016)

Mathematical modeling and parameter estimation of levodopa motor response in patients with parkinson disease
por: Ursino, Mauro, et al.
Publicado: (2020)

Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
por: Landes, Reid D., et al.
Publicado: (2022)

Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
por: Schröter, Nils, et al.
Publicado: (2022)

Screening for Cushing Syndrome at the Primary Care Level: What Every General Practitioner Must Know
por: Yorke, Ernest, et al.
Publicado: (2017)

Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
por: Conti, Valeria, et al.
Publicado: (2022)

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson's Disease
por: Nishijima, Haruo, et al.
Publicado: (2018)

Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
por: Senek, Marina, et al.
Publicado: (2017)

Levodopa-Induced Pseudopheochromocytoma
por: Cardoso, Joana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tjpn4use1rm4vnoaku5bt2r840